126 related articles for article (PubMed ID: 16914878)
1. Preclinical characterization of amyloid imaging probes with multiphoton microscopy.
Skoch J; Hyman BT; Bacskai BJ
J Alzheimers Dis; 2006; 9(3 Suppl):401-7. PubMed ID: 16914878
[TBL] [Abstract][Full Text] [Related]
2. Four-dimensional multiphoton imaging of brain entry, amyloid binding, and clearance of an amyloid-beta ligand in transgenic mice.
Bacskai BJ; Hickey GA; Skoch J; Kajdasz ST; Wang Y; Huang GF; Mathis CA; Klunk WE; Hyman BT
Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12462-7. PubMed ID: 14517353
[TBL] [Abstract][Full Text] [Related]
3. In vivo SPECT imaging of amyloid-β deposition with radioiodinated imidazo[1,2-a]pyridine derivative DRM106 in a mouse model of Alzheimer's disease.
Chen CJ; Bando K; Ashino H; Taguchi K; Shiraishi H; Shima K; Fujimoto O; Kitamura C; Matsushima S; Uchida K; Nakahara Y; Kasahara H; Minamizawa T; Jiang C; Zhang MR; Ono M; Tokunaga M; Suhara T; Higuchi M; Yamada K; Ji B
J Nucl Med; 2015 Jan; 56(1):120-6. PubMed ID: 25476539
[TBL] [Abstract][Full Text] [Related]
4. In vivo imaging of reactive oxygen species specifically associated with thioflavine S-positive amyloid plaques by multiphoton microscopy.
McLellan ME; Kajdasz ST; Hyman BT; Bacskai BJ
J Neurosci; 2003 Mar; 23(6):2212-7. PubMed ID: 12657680
[TBL] [Abstract][Full Text] [Related]
5. In Vivo Near-Infrared Two-Photon Imaging of Amyloid Plaques in Deep Brain of Alzheimer's Disease Mouse Model.
Chen C; Liang Z; Zhou B; Li X; Lui C; Ip NY; Qu JY
ACS Chem Neurosci; 2018 Dec; 9(12):3128-3136. PubMed ID: 30067906
[TBL] [Abstract][Full Text] [Related]
6. Binding of two potential imaging agents targeting amyloid plaques in postmortem brain tissues of patients with Alzheimer's disease.
Kung MP; Hou C; Zhuang ZP; Skovronsky D; Kung HF
Brain Res; 2004 Oct; 1025(1-2):98-105. PubMed ID: 15464749
[TBL] [Abstract][Full Text] [Related]
7. Non-Fc-mediated mechanisms are involved in clearance of amyloid-beta in vivo by immunotherapy.
Bacskai BJ; Kajdasz ST; McLellan ME; Games D; Seubert P; Schenk D; Hyman BT
J Neurosci; 2002 Sep; 22(18):7873-8. PubMed ID: 12223540
[TBL] [Abstract][Full Text] [Related]
8. Development of positron-emission tomography/single-photon emission computed tomography imaging probes for in vivo detection of beta-amyloid plaques in Alzheimer's brains.
Ono M
Chem Pharm Bull (Tokyo); 2009 Oct; 57(10):1029-39. PubMed ID: 19801854
[TBL] [Abstract][Full Text] [Related]
9. Development of a PET/SPECT agent for amyloid imaging in Alzheimer's disease.
Wang Y; Klunk WE; Debnath ML; Huang GF; Holt DP; Shao L; Mathis CA
J Mol Neurosci; 2004; 24(1):55-62. PubMed ID: 15314250
[TBL] [Abstract][Full Text] [Related]
10. Optical visualization of Alzheimer's pathology via multiphoton-excited intrinsic fluorescence and second harmonic generation.
Kwan AC; Duff K; Gouras GK; Webb WW
Opt Express; 2009 Mar; 17(5):3679-89. PubMed ID: 19259208
[TBL] [Abstract][Full Text] [Related]
11. [Development of SPECT Probes for In Vivo Imaging of β-Amyloid and Tau Aggregates in the Alzheimer's Disease Brain].
Watanabe H
Yakugaku Zasshi; 2017; 137(11):1361-1365. PubMed ID: 29093372
[TBL] [Abstract][Full Text] [Related]
12. Molecular targeting of Alzheimer's amyloid plaques for contrast-enhanced magnetic resonance imaging.
Poduslo JF; Wengenack TM; Curran GL; Wisniewski T; Sigurdsson EM; Macura SI; Borowski BJ; Jack CR
Neurobiol Dis; 2002 Nov; 11(2):315-29. PubMed ID: 12505424
[TBL] [Abstract][Full Text] [Related]
13. Novel botanical drug DA-9803 prevents deficits in Alzheimer's mouse models.
Pagnier GJ; Kastanenka KV; Sohn M; Choi S; Choi SH; Soh H; Bacskai BJ
Alzheimers Res Ther; 2018 Jan; 10(1):11. PubMed ID: 29378621
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer's disease: what multiphoton microscopy teaches us.
Bacskai BJ; Hyman BT
Neuroscientist; 2002 Oct; 8(5):386-90. PubMed ID: 12374422
[TBL] [Abstract][Full Text] [Related]
15. Amyloid imaging using fluorine-19 magnetic resonance imaging ((19)F-MRI).
Tooyama I; Yanagisawa D; Taguchi H; Kato T; Hirao K; Shirai N; Sogabe T; Ibrahim NF; Inubushi T; Morikawa S
Ageing Res Rev; 2016 Sep; 30():85-94. PubMed ID: 26772439
[TBL] [Abstract][Full Text] [Related]
16. Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease.
Garcia-Alloza M; Robbins EM; Zhang-Nunes SX; Purcell SM; Betensky RA; Raju S; Prada C; Greenberg SM; Bacskai BJ; Frosch MP
Neurobiol Dis; 2006 Dec; 24(3):516-24. PubMed ID: 17029828
[TBL] [Abstract][Full Text] [Related]
17. Detection of Aβ plaques by a novel specific MRI probe precursor CR-BSA-(Gd-DTPA)n in APP/PS1 transgenic mice.
Li S; He H; Cui W; Gu B; Li J; Qi Z; Zhou G; Liang CM; Feng XY
Anat Rec (Hoboken); 2010 Dec; 293(12):2136-43. PubMed ID: 21089051
[TBL] [Abstract][Full Text] [Related]
18. Utilizing advanced imaging and surrogate markers across the spectrum of Alzheimer's disease.
Mintun MA
CNS Spectr; 2005 Nov; 10(11 Suppl 18):13-6. PubMed ID: 16273025
[TBL] [Abstract][Full Text] [Related]
19. [Amyloid-plaque imaging of the brain using PET].
Ossenkoppele R; Tolboom N; Pijnenburg YA; Lammertsma AA; Scheltens P; van Berckel BN
Ned Tijdschr Geneeskd; 2011; 155():A2981. PubMed ID: 21586182
[TBL] [Abstract][Full Text] [Related]
20. Molecular approaches to the treatment, prophylaxis, and diagnosis of Alzheimer's disease: novel PET/SPECT imaging probes for diagnosis of Alzheimer's disease.
Ono M; Saji H
J Pharmacol Sci; 2012; 118(3):338-44. PubMed ID: 22382657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
